Testing when unknown
Download
Report
Transcript Testing when unknown
Hypothesis Testing
9
Copyright © Cengage Learning. All rights reserved.
Section
9.2
Testing the Mean
Copyright © Cengage Learning. All rights reserved.
Focus Points
•
Test when is unknown using a Student’s t
distribution.
3
Part II: Testing when
is unknown
4
Part II: Testing when is unknown
In many real-world situations, you have only a random
sample of data values. In addition, you may have some
limited information about the probability distribution of your
data values.
Can you still test under these circumstances? In most
cases, the answer is yes!
5
Part II: Testing when is unknown
Procedure:
6
Part II: Testing when is unknown
Procedure:
7
Part II: Testing when is unknown
We used Table 4 of the Appendix, “Critical Values for
Student’s t Distribution”, to find critical values tc for
confidence intervals. The critical values are in the body of
the table.
8
Example 4 – Testing when unknown
The drug 6-mP (6-mercaptopurine) is used to treat
leukemia. The following data represent the remission times
(in weeks) for a random sample of 21 patients using 6-mP
(Reference: E. A. Gehan, University of Texas Cancer
Center).
The sample mean is 17.1 weeks, with sample standard
deviation s 10.0. Let x be a random variable representing
the remission time (in weeks) for all patients using 6-mP.
9
Example 4 – Testing when unknown
cont’d
Assume the x distribution is mound-shaped and symmetric.
A previously used drug treatment had a mean remission
time of = 12.5 weeks.
Do the data indicate that the mean remission time using the
drug 6-mP is different (either way) from 12.5 weeks? Use
= 0.01.
10
11
Example 4 – Solution
(a) Establish the null and alternate hypotheses.
Since we want to determine if the drug 6-mP provides a
mean remission time that is different from that provided
by a previously used drug having = 12.5 weeks,
H0: = 12.5 weeks
and
H1: 12.5 weeks
(b) Check Requirements What distribution do we use for
the sample test statistic t? Compute the sample test
statistic from the sample data.
The x distribution is assumed to be mound-shaped and
symmetric.
12
Example 4 – Solution
cont’d
Because we don’t know , we use a Student’s t
distribution with d.f. = 20. Using 17.1 and s 10.0
from the sample data, = 12.5 from H0, and n = 21
13
Example 4 – Solution
cont’d
(c) Find the P-value or the interval containing the P-value.
Figure 9-5 shows the P-value. Using Table 4 of the
Appendix, we find an interval containing the P-value.
P-value
Figure 9-5
14
Example 4 – Solution
cont’d
Since this is a two-tailed test, we use entries from the
row headed by two-tail area. Look up the t value in the
row headed by d.f. = n – 1 = 21 – 1 = 20.
The sample statistic t = 2.108 falls between 2.086 and
2.528. The P-value for the sample t falls between the
corresponding two-tail areas 0.050 and 0.020.
(See Table 9-5.) 0.020 < P-value < 0.050
Excerpt from Student’s t Distribution (Table 4, Appendix)
Table 9-5
15
Example 4 – Solution
cont’d
(d) Conclude the test.
The following diagram shows the interval that contains
the single P-value corresponding to the test statistic.
Note that there is just one P-value corresponding to the
test statistic. Table 4 of the Appendix does not give that
specific value, but it does give a range that contains that
specific P-value.
As the diagram shows, the entire range is greater than
. This means the specific P-value is greater than , so
we cannot reject H0.
16
Example 4 – Solution
cont’d
Note:
Using the raw data, computer software gives
P-value 0.048. This value is in the interval we
estimated. It is larger than the value of 0.01, so we do
not reject H0.
(e) Interpretation Interpret the results in the context of the
problem. At the 1% level of significance, the evidence is
not sufficient to reject H0. Based on the sample data, we
cannot say that the drug 6-mP provides a different
average remission time than the previous drug.
17
18
19
20